Drug & Device Pipeline News
| Company | Drug/Device | Medical Condition | Status |
|---|---|---|---|
| Trials Authorized | |||
| Cellevolve | CE-VST01-JC | Progressive multifocal leukoencephalopathy | IND approved by the FDA |
| Cour Pharmaceuticals | CNP-106 | Myasthenia gravis | IND approved by the FDA |
| Nihon Medi-Physics | NMK89 | Cancer diagnostic | IND approved by the FDA |
| Trials Initiated | |||
| Anixa Biosciences | Breast cancer vaccine | Breast cancer | Initiation of phase 1b trial |
| Bio-Path Holdings | BP1002 | Refractory/relapsed acute myeloid leukemia | Initiation of phase 1/1b trial |
| Corvus Pharmaceuticals | Ciforadenant plus ipilimumab and nivolumab | Metastatic renal cell cancer | Initiation of phase 1b/2 trial |
| Sensorion | SENS-401 (arazasetron) | Cisplatin-induced ototoxicity | Initiation of a phase 2a trial in France |
| Aphaia Pharma | APH-012 | Chronic weight management in people with obesity | Initiation of phase 2 trial |
| Neurocrine Biosciences | NBI-1117568 | Schizophrenia in adults | Initiation of phase 2 trial |
| Seelos Therapeutics | SLS-005 (trehalose injection) | Spinocerebellar ataxia type 3 | Initiation of phase 2/3 trial |
| HUTCHMED | Fruquintinib plus sintilimab | Second-line treatment for locally advanced or metastatic renal cell carcinoma | Initiation of phase 2/3 trial in China |
| Boehringer Ingelheim | BI 1015550 | Idiopathic pulmonary fibrosis | Initiation of phase 3 trial |
| Codagenix | CoviLiv COVID-19 vaccine | COVID-19 | Initiation of phase 3 trial |
| Finch Therapeutics | CP101 | Recurrent C. difficile infection | Initiation of phase 3 trial |
| Approvals | |||
| AbbVie | Rinvoq (upadacitinib) | Nonradiographic axial spondyloarthritis in adults | Approved by the FDA for new indication |
| AstraZeneca | Imjudo (tremelimumab) plus Imfinzi (durvalumab) | Unresectable hepatocellular carcinoma in adults | Approved by the FDA |
| Johnson & Johnson | Tecvayli (teclistamab-cqyv) | Relapsed or refractory multiple myeloma in adults | Approved by the FDA |
Upcoming Events
-
08Dec
-
13Dec
